1640.8000 -72.70 (-4.24%)
NSE Jan 19, 2026 09:07 AM
Volume: 364
 

1640.80
-4.24%
ICICI Securities Limited
Poly Medicure’s (Polymed) Q3FY23 performance beats our estimates on all fronts. Revenue grew 23.7% YoY to Rs2.8bn (I-Sec: Rs2.7bn) led by strong demand across segments. EBITDA margin improved 270bps YoY and 140bps QoQ to 24.9%, supported by strong gross margin expansion.
Poly Medicure has lost -26.06% in the last 6 Months
More from Poly Medicure Ltd.
Recommended